E. Deml

693 total citations
29 papers, 531 citations indexed

About

E. Deml is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, E. Deml has authored 29 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 11 papers in Molecular Biology and 8 papers in Health, Toxicology and Mutagenesis. Recurrent topics in E. Deml's work include Carcinogens and Genotoxicity Assessment (16 papers), Drug Transport and Resistance Mechanisms (6 papers) and Toxic Organic Pollutants Impact (6 papers). E. Deml is often cited by papers focused on Carcinogens and Genotoxicity Assessment (16 papers), Drug Transport and Resistance Mechanisms (6 papers) and Toxic Organic Pollutants Impact (6 papers). E. Deml collaborates with scholars based in Germany, Switzerland and Austria. E. Deml's co-authors include Doris Oesterle, T. Wolff, Helmut Greim, L.R. Schwarz, Friedrich J. Wiebel, Karl K. Rozman, John Doull, Bernhard Stahl, Jan Topinka and J. G. Filser and has published in prestigious journals such as Carcinogenesis, Cancer Letters and Food and Chemical Toxicology.

In The Last Decade

E. Deml

29 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Deml Germany 13 222 182 168 157 78 29 531
Doris Oesterle Germany 14 250 1.1× 140 0.8× 194 1.2× 73 0.5× 45 0.6× 42 556
Ronny Fransson-Steen Sweden 15 198 0.9× 121 0.7× 259 1.5× 109 0.7× 35 0.4× 23 605
Tamie Nakajima Japan 13 281 1.3× 127 0.7× 149 0.9× 393 2.5× 100 1.3× 24 683
Elroy T. Cantrell United States 14 300 1.4× 169 0.9× 209 1.2× 214 1.4× 69 0.9× 27 654
Anne‐Marie Camus France 13 268 1.2× 95 0.5× 394 2.3× 228 1.5× 69 0.9× 16 735
Masataka Kagawa Japan 12 298 1.3× 73 0.4× 398 2.4× 98 0.6× 76 1.0× 16 741
Toyohiko Aoki Japan 14 295 1.3× 101 0.6× 394 2.3× 108 0.7× 55 0.7× 38 757
A.A.J. van Iersel Netherlands 9 65 0.3× 153 0.8× 227 1.4× 239 1.5× 49 0.6× 14 636
Rochelle M. Long United States 14 129 0.6× 72 0.4× 332 2.0× 198 1.3× 46 0.6× 25 694
Philip Wiebkin United Kingdom 13 81 0.4× 65 0.4× 135 0.8× 210 1.3× 47 0.6× 23 503

Countries citing papers authored by E. Deml

Since Specialization
Citations

This map shows the geographic impact of E. Deml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Deml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Deml more than expected).

Fields of papers citing papers by E. Deml

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Deml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Deml. The network helps show where E. Deml may publish in the future.

Co-authorship network of co-authors of E. Deml

This figure shows the co-authorship network connecting the top 25 collaborators of E. Deml. A scholar is included among the top collaborators of E. Deml based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Deml. E. Deml is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ittrich, Carina, E. Deml, Doris Oesterle, et al.. (2003). Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report. Toxicologic Pathology. 31(1). 60–79. 10 indexed citations
2.
Ittrich, Carina, E. Deml, Doris Oesterle, et al.. (2003). Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report. Toxicologic Pathology. 31(1). 60–79. 3 indexed citations
3.
Lahm, Harald, Ottheinz Krebs, Lisa Sprague, et al.. (2002). Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice. Growth Hormone & IGF Research. 12(1). 69–79. 15 indexed citations
4.
Wolff, T., Jan Topinka, E. Deml, Doris Oesterle, & L.R. Schwarz. (2001). Dose Dependent Induction of DNA Adducts, Gene Mutations, and Cell Proliferation by the Antiandrogenic Drug Cyproterone Acetate in Rat Liver. Advances in experimental medicine and biology. 500. 687–696. 8 indexed citations
5.
Rozman, Karl K., et al.. (1996). A Toxicologist's View of Cancer Risk Assessment. Drug Metabolism Reviews. 28(1-2). 29–52. 43 indexed citations
6.
Deml, E., et al.. (1994). C-raf expression in early rat liver tumorigenesis after promotion with polychlorinated biphenyls or phenobarbital. Xenobiotica. 24(6). 569–580. 8 indexed citations
7.
Deml, E., L.R. Schwarz, & Doris Oesterle. (1993). Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay. Carcinogenesis. 14(6). 1229–1231. 24 indexed citations
8.
Oesterle, Doris & E. Deml. (1990). Detection of chemical carcinogens by means of the “rat liver foci bioassay”. Experimental Pathology. 39(3-4). 197–206. 9 indexed citations
9.
Denk, B., et al.. (1990). Dose-dependent emergence of preneoplastic foci in rat livers after exposure to 2-nitropropane. Archives of Toxicology. 64(4). 329–331. 2 indexed citations
10.
Oesterle, Doris, et al.. (1990). Di(2-ethylhexyl)phthalate alters carbohydrate enzyme activites and foci incidence in rat liver. Carcinogenesis. 11(12). 2111–2115. 6 indexed citations
11.
Oesterle, Doris, et al.. (1989). Comparison of three rat liver foci bioassays-incidence of preneoplastic foci initiated by diethylnitrosamine. Carcinogenesis. 10(10). 1891–1895. 9 indexed citations
12.
Deml, E., Friedrich J. Wiebel, & Doris Oesterle. (1989). Biological activity of 2,4,8-trichlorodibenzofuran: promotion of rat liver foci and induction of cytochrome P-450-dependent monooxygenases. Toxicology. 59(3). 229–238. 5 indexed citations
13.
Oesterle, Doris & E. Deml. (1988). Lack of initiating and promoting activity of thiourea in rat liver foci bioassay. Cancer Letters. 41(3). 245–249. 5 indexed citations
14.
Denk, B., J. G. Filser, Doris Oesterle, E. Deml, & Helmut Greim. (1988). Inhaled ethylene oxide induces preneoplastic foci in rat liver. Journal of Cancer Research and Clinical Oncology. 114(1). 35–38. 6 indexed citations
15.
Oesterle, Doris & E. Deml. (1988). Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci bioassay. Journal of Cancer Research and Clinical Oncology. 114(2). 133–136. 13 indexed citations
16.
Deml, E. & Doris Oesterle. (1987). Dose-response of promotion by polychlorinated biphenyls and chloroform in rat liver foci bioassay. Archives of Toxicology. 60(1-3). 209–211. 18 indexed citations
17.
Deml, E., et al.. (1984). Drugs and environmental chemicals as promoters.. PubMed. 487–94. 6 indexed citations
18.
Deml, E., et al.. (1983). Effects of polychlorinated biphenyls at low dose levels in rats. Archives of Environmental Contamination and Toxicology. 12(5). 509–515. 16 indexed citations
19.
Deml, E., Doris Oesterle, T. Wolff, & Helmut Greim. (1981). Age-, sex-, and strain-dependent differences in the induction of enzyme-altered islands in rat liver by diethylnitrosamine. Journal of Cancer Research and Clinical Oncology. 100(2). 125–134. 22 indexed citations
20.
Wolff, T., et al.. (1979). Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.. Drug Metabolism and Disposition. 7(5). 301–305. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris Oesterle Breakdown of academic impact, for papers by Ronny Fransson-Steen Breakdown of academic impact, for papers by Tamie Nakajima Breakdown of academic impact, for papers by Elroy T. Cantrell Breakdown of academic impact, for papers by Anne‐Marie Camus Breakdown of academic impact, for papers by Masataka Kagawa Breakdown of academic impact, for papers by Toyohiko Aoki Breakdown of academic impact, for papers by A.A.J. van Iersel Breakdown of academic impact, for papers by Rochelle M. Long Breakdown of academic impact, for papers by Philip Wiebkin
Rankless by CCL
2026